However, inhibiting ceramide synthase and sphingosine kinase enzymes also unlocks the possibility of using Jaspine B to treat inflammatory and immune-related diseases, including rheumatoid arthritis, inflammatory bowel disease, and Alzheimer’s disease [38,39]. This evidence concerns the gene TLCD3B and early-onset autosomal dominant Alzheimer disease.